Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible Patients

被引：4
作者：
Gonsalves, Wilson I. [1 ]
Kansagra, Ankit [2 ]
机构：
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
[2] UT Southwestern, Dept Med, Hematol, Dallas, TX USA
来源：
ACTA HAEMATOLOGICA | 2018年 / 139卷 / 01期
关键词：
D O I：
10.1159/000486272
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：45 / 46
页数：2
相关论文
共 6 条
  • [1] The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial
    Cook, Gordon
    Ashcroft, A. John
    Cairns, David A.
    Williams, Cathy D.
    Brown, Julia M.
    Cavenagh, Jamie D.
    Snowden, John A.
    Parrish, Christopher
    Yong, Kwee
    Cavet, Jim
    Hunter, Hannah
    Bird, Jenny M.
    Pratt, Guy
    Chown, Sally
    Heartin, Ernest
    O'Connor, Sheila
    Drayson, Mark T.
    Hockaday, Anna
    Morris, Treen C. M.
    [J]. LANCET HAEMATOLOGY, 2016, 3 (07): : E340 - E351
  • [2] Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
    Gonsalves, W. I.
    Rajkumar, S. V.
    Gertz, M. A.
    Dispenzieri, A.
    Lacy, M. Q.
    Buadi, F. K.
    Dingli, D.
    Go, R. S.
    Leung, N.
    Kapoor, P.
    Hayman, S. R.
    Lust, J. A.
    Russell, S. J.
    Zeldenrust, S. R.
    Hwa, Y. L.
    Kourelis, T. V.
    Kyle, R. A.
    Kumar, S. K.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (08) : 1156 - 1158
  • [3] Second auto-SCT for treatment of relapsed multiple myeloma
    Gonsalves, W. I.
    Gertz, M. A.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Buadi, F. K.
    Dingli, D.
    Hogan, W. J.
    Kumar, S. K.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (04) : 568 - 573
  • [4] Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
    Kumar, S. K.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Pandey, S.
    Kapoor, P.
    Dingli, D.
    Hayman, S. R.
    Leung, N.
    Lust, J.
    McCurdy, A.
    Russell, S. J.
    Zeldenrust, S. R.
    Kyle, R. A.
    Rajkumar, S. V.
    [J]. LEUKEMIA, 2014, 28 (05) : 1122 - 1128
  • [5] Autologous stem cell transplant for multiple myeloma patients 70 years or older
    Muchtar, E.
    Dingli, D.
    Kumar, S.
    Buadi, F. K.
    Dispenzieri, A.
    Hayman, S. R.
    Wolf, R. C.
    Gastineau, D. A.
    Chakraborty, R.
    Hogan, W. J.
    Leung, N.
    Kapoor, P.
    Lacy, M. Q.
    Rajkumar, S. V.
    Gertz, M. A.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1449 - 1455
  • [6] Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan
    Muta, Tsuyoshi
    Miyamoto, Toshihiro
    Kamimura, Tomohiko
    Kanda, Yoshinobu
    Nohgawa, Masaharu
    Ueda, Yasunori
    Iwato, Koji
    Sasaki, Osamu
    Mori, Takehiko
    Uchida, Naoyuki
    Iida, Shinsuke
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Sunami, Kazutaka
    [J]. ACTA HAEMATOLOGICA, 2018, 139 (01) : 35 - 44
1